Advancing Evidence for Global Implementation of Spatial Repellents – Social sciences component
John Hopkins Centre for Communications Program (CCP) and the Department of International Health at the Johns Hopkins School of Public Health (JHSPH) are leading the social science portion of a five-year, $33.7 million grant from […]
Read more
Takeda Dengue Vaccine Listing [Clinical trials in Sri Lanka]
The European Medicines Agency’s (EMA) Human Medicines Committee (CHMP) has recommended the use of Takeda’s Dengue Tetravalent Vaccine, to prevent disease caused by dengue virus serotypes 1, 2, 3 and 4 in people from four […]
Read more
13 Years of clinical trial excellence in Sri Lanka :Clinical trials in Sri Lanka
On 27 NOV 2022 RemediumOne celebrated 13 years of success in executing clinical trials in Sri Lanka. We are looking forward to serve our best in coming years. LinkedIn-RemediumOne
Read more
Clinical trials & Clinical Research in Sri Lanka : Real World Evidence: A Local Perspective
Real World Evidence: A Local Perspective The U.S. Food and Drug Administration (FDA) defines Real World Evidence (RWE) as “the clinical evidence regarding the usage and potential benefits or risks of a medical product / […]
Read more
Sri Lanka clinical trial: Novel approach in dengue vector control. Dengue Spatrial repellent work in Sri Lanka.
Dengue is an endemic disease in Sri Lanka and in many tropical countries. Though the mortality is controlled through clinical intervention the financial burden the disease exert on healthcare system is high. Innovative methods are […]
Read more
Prof. Anthony Rodgers discussing Single-pill, multi-mechanism combination therapies in novel and unique dosage strengths in Sri Lanka
Single-pill, multi-mechanism combination therapies in novel and unique dosage strengths, targeting some of the leading causes of death is one of the research interests of Prof. Anthony Rodgers. In his recent visit to Sri Lanka Prof. Anthony […]
Read more
Prof Asita de Silva, founder of RemediumOne, among the Stanford-Elsevier list of the World’s Top 2% of Scientists
We are delighted to share that Prof Asita de Silva, founder of RemediumOne, has been ranked on the list of the World’s Top 2% of Scientists for the second time in a row. Stanford University […]
Read more
ISE Abstract Award for research on gestational diabetes
We are happy to inform that International Society of Endocrinology (ISE) has awarded Saumiyah Ajanthan an abstract Award. The research was on gestational diabetes. ISE traditionally awards at each International Congress of Endocrinology (ICE) a […]
Read more
Sri Lanka’s health authority relaxed the face mask mandate in June 2022
Sri Lanka’s health authority relaxed the face mask mandate in June 2022, due to decrease in reported COVID-19 infections in the country. The Director General of Health Services released a press release today (26 Jul […]
Read more
New Year Message from RemediumOne (Clinical Research Service Provider in Sri Lanka)
A much awaited time of the year in Sri Lanka, the “Sinhala and Tamil new year” is celebrated in many households mainly Buddhist and Hindu, as the sun moves from Pisces to Aries marking the […]
Read more